Authors:
MAST AE
HIGUCHI DA
HUANG ZF
WARSHAWSKY I
SCHWARTZ AL
BROZE GJ
Citation: Ae. Mast et al., GLYPICAN-5 IS A BINDING-PROTEIN ON THE HEPG2 CELL-SURFACE FOR TISSUE FACTOR PATHWAY INHIBITOR, Biochemical journal, 327, 1997, pp. 577-583
Authors:
OBERMOELLER LM
WARSHAWSKY I
WARDELL MR
BU GJ
Citation: Lm. Obermoeller et al., DIFFERENTIAL FUNCTIONS OF TRIPLICATED REPEATS SUGGEST 2 INDEPENDENT ROLES FOR THE RECEPTOR-ASSOCIATED PROTEIN AS A MOLECULAR CHAPERONE, The Journal of biological chemistry, 272(16), 1997, pp. 10761-10768
Citation: I. Warshawsky et Al. Schwartz, THE 39-KDA PROTEIN REGULATES LRP ACTIVITY IN CULTURED ENDOTHELIAL ANDSMOOTH-MUSCLE CELLS, European journal of cell biology, 69(2), 1996, pp. 156-165
Citation: I. Warshawsky et al., THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN CAN FUNCTION INDEPENDENTLY FROM HEPARAN-SULFATE PROTEOGLYCANS IN TISSUE FACTOR PATHWAYINHIBITOR ENDOCYTOSIS, The Journal of biological chemistry, 271(42), 1996, pp. 25873-25879
Authors:
MAST AE
HUANG ZF
WARSHAWSKY I
SCHWARTZ AL
BROZE GJ
Citation: Ae. Mast et al., GLYPICAN-3 IS A TISSUE FACTOR PATHWAY INHIBITOR BINDING-PROTEIN ON THE HEPG2 CELL-SURFACE, Blood, 88(10), 1996, pp. 1866-1866
Authors:
WARSHAWSKY I
BU GJ
MAST A
SAFFITZ JE
BROZE GJ
SCHWARTZ AL
Citation: I. Warshawsky et al., THE CARBOXY-TERMINUS OF TISSUE FACTOR PATHWAY INHIBITOR IS REQUIRED FOR INTERACTING WITH HEPATOMA-CELLS IN-VITRO AND IN-VIVO, The Journal of clinical investigation, 95(4), 1995, pp. 1773-1781
Authors:
NIELSEN MS
NYKJAER A
WARSHAWSKY I
SCHWARTZ AL
GLIEMANN J
Citation: Ms. Nielsen et al., ANALYSIS OF LIGAND-BINDING TO THE ALPHA(2)-MACROGLOBULIN RECEPTOR LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN - EVIDENCE THAT LIPOPROTEIN LIPASE AND THE CARBOXYL-TERMINAL DOMAIN OF THE RECEPTOR-ASSOCIATEDPROTEIN BIND TO THE SAME SITE, The Journal of biological chemistry, 270(40), 1995, pp. 23713-23719
Citation: I. Warshawsky et al., SITES WITHIN THE 39-KDA PROTEIN IMPORTANT FOR REGULATING LIGAND-BINDING TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN, Biochemistry, 34(10), 1995, pp. 3404-3415
Citation: I. Warshawsky et al., THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN MEDIATES THE CELLULAR DEGRADATION OF TISSUE FACTOR PATHWAY INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(14), 1994, pp. 6664-6668
Citation: I. Warshawsky et al., BINDING ANALYSIS OF AMINO-TERMINAL AND CARBOXYL-TERMINAL REGIONS OF THE 39-KDA PROTEIN TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN, The Journal of biological chemistry, 269(5), 1994, pp. 3325-3330
Citation: I. Warshawsky et al., 39-KD PROTEIN INHIBITS TISSUE-TYPE PLASMINOGEN-ACTIVATOR CLEARANCE IN-VIVO, The Journal of clinical investigation, 92(2), 1993, pp. 937-944
Citation: I. Warshawsky et al., IDENTIFICATION OF DOMAINS ON THE 39-KDA PROTEIN THAT INHIBIT THE BINDING OF LIGANDS TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN, The Journal of biological chemistry, 268(29), 1993, pp. 22046-22054
Citation: Mx. Gu et al., CLONING AND EXPRESSION OF A CYTOSOLIC MEGAKARYOCYTE PROTEIN-TYROSINE-PHOSPHATASE WITH SEQUENCE HOMOLOGY TO RETINALDEHYDE-BINDING PROTEIN AND YEAST SEC14P, Proceedings of the National Academy of Sciences of the United Statesof America, 89(7), 1992, pp. 2980-2984